$BDSX News
Last published 1d ago
- 1d agoBDSXUBS Global Healthcare Conference - BIODESIX INCEarnings Call TranscriptsAll right. Good afternoon. My name is Doug Schenkel. On behalf of UBS, it is my pleasure to welcome Robin Cowie, Chief Financial Officer, and Tim DuPont, Head of Sales Operations and Project Manager, as well as Leader fo
- 2d agoBDSXBIODESIX, INC. INVESTIGATION: BDSX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their RightsGlobeNewswireNEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Biodesix, Inc. ("Biodesix" or the "Company") (NASDAQ:BDSX). The investigation
- 2d agoBDSXBIODESIX, INC. INVESTIGATION: BDSX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their RightsGlobeNewswireNEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Biodesix, Inc. (“Biodesix” or the “Company”) (NASDAQ: BDSX). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired ...
- 2d agoBDSXBiodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual MeetingGlobeNewswireNew data highlighting proprietary bioinformatics, ultrasensitive molecular detection, and collaborations with Bio-Rad Laboratories and Thermo Fisher Scientific to advance scalable MRD solutions for clinical laboratories
- 2d agoBDSXBiodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual MeetingGlobeNewswireLOUISVILLE, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced it will present new data from its tumor-informed and tumor-naïve molecular
- 6d agoBDSXBIODESIX INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoBDSXBiodesix Announces Third Quarter 2026 Results and HighlightsGlobeNewswireDelivered total revenue of $24.0 million, an increase of 10% year over year Grew Diagnostic Testing revenue 16% year over year, with test volumes increasing 24% Maintained an 81% gross margin, improved Net loss
- 1w agoBDSXBiodesix to Participate in Upcoming Investor ConferencesGlobeNewswireLOUISVILLE, Colo., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present at two upcoming
- 2w agoBDSXBiodesix to Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewswireLOUISVILLE, Colo., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September
- 3w agoBDSXAmerican College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk StratificationGlobeNewswireLOUISVILLE, Colo., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc (NASDAQ:BDSX), a leader in diagnostic solutions, today announced that the American College of Chest Physicians (CHEST) has published a new framework
- 3w agoBDSXBiodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging BiomarkersGlobeNewswireLOUISVILLE, Colo., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced the addition of Digital Diagnostics to its Lung Diagnostics strategy,
- 4w agoBDSXBiodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026GlobeNewswireLOUISVILLE, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced multiple presentations at CHEST 2026 highlighting how Nodify Lung testing is
- 1mo agoBDSXBiodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual MeetingsGlobeNewswireLOUISVILLE, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that Brianna Phillips, Vice President of Quality and Regulatory Affairs at
- 2mo agoBDSXBiodesix to Participate in Upcoming Investor ConferencesGlobeNewswireLOUISVILLE, Colo., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present in three upcoming
- 3mo agoBDSXCG 46TH ANNUAL GROWTH CONFERENCE - BIODESIX INCEarnings Call TranscriptsHello and welcome to the 46th Annual Kennecor Genuity Growth Conference. I'm Alex Vikason and I'm a member of the Life Science Tools and Diagnostics team here at Kennecore Genuity. We're pleased to have BioDesics here wi
- 3mo agoBDSXCG 46TH ANNUAL GROWTH CONFERENCE - BIODESIX INCEarnings Call TranscriptsHello and welcome to the 46th Annual Kennecor Genuity Growth Conference. I'm Alex Vikason and I'm a member of the Life Science Tools and Diagnostics team here at Kennecore Genuity. We're pleased to have BioDesics here wi
- 3mo agoBDSXBiodesix Announces Second Quarter 2026 Results and HighlightsGlobeNewswireDelivered $26.9 million in revenue, representing 34% growth in Q2 2026; Achieved 82% gross margin in Q2 2026; Maintained FY 2026 Revenue Guidance of $108-114 million, mid-point reflects 25% growth; Conference Call
- 3mo agoBDSXBiodesix to Participate in Canaccord Genuity’s 46th Annual Growth ConferenceGlobeNewswireLOUISVILLE, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present in a fireside chat
- 3mo agoBDSXBiodesix to Report Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireLOUISVILLE, Colo., July 22, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the second quarter ended June 30,
- 5mo agoBDSXBiodesix to Participate in Upcoming Investor ConferencesGlobeNewswireLOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming
- 6mo agoBDSXBiodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing StrategyGlobeNewswireLOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related to Nodify
- 6mo agoBDSXBiodesix Announces First Quarter 2026 Results and HighlightsGlobeNewswireDelivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in Q1 2026; Increased FY 2026 Revenue Guidance to $108-114 million, mid-point reflects 25% growth; Conference Call
- 6mo agoBDSXBiodesix to Report First Quarter 2026 Financial Results on May 4, 2026GlobeNewswireLOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31,
- 7mo agoBDSXBiodesix Recognized as a Top Workplace for Third Consecutive YearGlobeNewswireLOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Biodesix is proud to announce that it has earned the prestigious 2026 USA TODAY Top Workplaces award. The award honors organizations with 150+ employees that have
- 7mo agoBDSXBiodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline DevelopmentGlobeNewswireLOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions,
- 8mo agoBDSXBiodesix Q4 2025 Earnings Conference Call - BIODESIX INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Biodesics fourth quarter 2025 earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a q
- 8mo agoBDSXBiodesix Announces Fourth Quarter and Fiscal Year 2025 Results and HighlightsGlobeNewswireDelivered 41% revenue growth and 83% gross margin in Q4 2025; Improved Net Loss by 52% and achieved first-ever Adjusted EBITDA positivity in Q4 2025; FY2026 Revenue Guidance of $106-112 million, mid-point reflects 23%
- 8mo agoBDSXBiodesix to Participate in Upcoming Investor ConferencesGlobeNewswireLOUISVILLE, Colo., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team will participate in two upcoming
- 9mo agoBDSXBiodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026GlobeNewswireLOUISVILLE, Colo., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the fourth quarter and year ended
- 10mo agoBDSXBiodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)GlobeNewswireEstimated Q4 2025 Revenue of $28.8 million, an increase of 41%; Grew full-year revenue to an estimated $88.5 million, an increase of 24%; Affirms guidance of Adjusted EBITDA positivity in Q4 2025. LOUISVILLE,
- 11mo agoBDSXBiodesix to Present New Data at Two Major Upcoming Scientific MeetingsGlobeNewswireClinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for earlier diagnosis of lung cancer Development data for a new
- 1y agoBDSXBiodesix Announces Third Quarter 2025 Results and HighlightsGlobeNewswireQ3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024; Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 2024; Raised FY2025 Total Revenue Guidance to $84-86 million; Conference
- 1y agoBDSXBIODESIX Q3 2025 Earnings Conference Call - BIODESIX INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the biodesk's third quarter 2025 earnings conference call. At this time all participants are in a listen only mode. After the speaker's presentation there'll be a questi
- 1y agoBDSXBiodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual MeetingGlobeNewswireLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP
- 1y agoBDSXBiodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity AssaysGlobeNewswireLOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE:BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will
- 1y agoBDSXBiodesix to Report Third Quarter 2025 Financial Results on November 3, 2025GlobeNewswireLOUISVILLE, Colo., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September
- 1y agoBDSXBiodesix Announces Presentations and Events at the CHEST 2025 Annual MeetingGlobeNewswireLOUISVILLE, Colo., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostics solutions company, announces educational events, abstracts, and activities at the 2025 CHEST Annual Meeting,
- 1y agoBDSXBiodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence SummitGlobeNewswireBiodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients LOUISVILLE, Colo., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc.
- 1y agoBDSXBiodesix Announces One-for-Twenty Reverse Stock SplitGlobeNewswireLOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX) ("Biodesix" or the "Company"), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock split (the "Reverse
- 1y agoBDSXBiodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) ConferenceGlobeNewswireLOUISVILLE, Colo., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced Robin Cowie, Chief Financial Officer, will host in-person 1x1 investor
- 1y agoBDSXBiodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS DiagnosticsGlobeNewswireLOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE)
- 1y agoBDSXBiodesix, Inc. (BDSX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBDSXBiodesix Announces Second Quarter 2025 Results and HighlightsGlobeNewswireQ2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85
- 1y agoBDSXBiodesix to Present at the Canaccord Genuity 45th Annual Growth ConferenceGlobeNewswireBOULDER, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced Scott Hutton, Chief Executive Officer, and Robin Cowie, Chief Financial Officer,
- 1y agoBDSXBiodesix to Report Second Quarter 2025 Financial Results on August 7, 2025GlobeNewswireLOUISVILLE, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the second quarter ended June 30,
- 1y agoBDSXBiodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer ProgramsGlobeNewswireLOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, announced today that it is partnering with the Association of Pulmonary Advanced Practice
- 1y agoBDSXBiodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual MeetingGlobeNewswireLOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical
- 1y agoBDSXBiodesix to Participate in Upcoming Investor ConferencesGlobeNewswireLOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming
- 1y agoBDSXBiodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATSGlobeNewswireLOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics and
- 1y agoBDSXDenver Post Names Biodesix a Winner of Top Workplaces 2025 AwardGlobeNewswireLOUISVILLE, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, is pleased to announce that it is a Colorado Top Workplaces 2025 Winner. The Top Workplaces